Discovering The Potential Drug Target ACKR2: Unlocking Its Functions and Interactions

Target Name: ACKR2

NCBI ID: G1238

ACKR2

Discovering The Potential Drug Target ACKR2: Unlocking Its Functions and Interactions

The chemokine (C-C motif) receptor 9 (ACKR2) is a G protein-coupled receptor that plays a crucial role in the regulation of cellular processes such as inflammation, immune responses, and sensory perception. The ACKR2 receptor has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will discuss the structure, function, and potential drug targets of ACKR2.

Structure and Function

The ACKR2 receptor is a G protein-coupled receptor that consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain is responsible for the formation of the extracellular portion of the receptor, which includes a C-C motif that plays a critical role in its stability and interactions with ligands. The transmembrane domain is responsible for the formation of the membrane of the receptor and is involved in the regulation of the receptor's internal signaling pathway. The intracellular domain is responsible for the interaction of the receptor with intracellular signaling pathways and is involved in the regulation of the receptor's signaling pathway.

The ACKR2 receptor is involved in the regulation of various cellular processes, including inflammation, immune responses, and sensory perception. The ACKR2 receptor is involved in the regulation of inflammation by promoting the production of pro-inflammatory cytokines and activating immune cells such as neutrophils. The ACKR2 receptor is also involved in the regulation of the immune response by promoting the activation and proliferation of T-cells and B-cells.

The ACKR2 receptor is also involved in the regulation of sensory perception by mediating the effects of pain and stress on the nervous system. The ACKR2 receptor is involved in the regulation of pain perception by mediating the effects of noxious stimuli on the nervous system and modulating the production of endogenous opioids. The ACKR2 receptor is also involved in the regulation of stress response by modulating the production of pro-inflammatory cytokines and activating immune cells.

Drug Targets

The ACKR2 receptor is a potential drug target due to its involvement in various cellular processes that are associated with the development and progression of diseases. The ACKR2 receptor is a good candidate for anti-inflammatory drugs, as it is involved in the regulation of inflammation and immune responses.

One of the potential drug targets for ACKR2 is the inhibition of inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6. These cytokines are involved in the regulation of inflammation and immune responses and have been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The ACKR2 receptor is involved in the regulation of the production of these cytokines, and inhibition of ACKR2 may be an effective way to treat these diseases.

Another potential drug target for ACKR2 is the inhibition of immune cell proliferation and activation. The ACKR2 receptor is involved in the regulation of T-cell proliferation and differentiation, as well as B-cell activation and proliferation. The inhibition of ACKR2 may be an effective way to treat autoimmune disorders and cancer, as these conditions are often characterized by the overregulation of immune cells.

Conclusion

The ACKR2 receptor is a G protein-coupled receptor that is involved in the regulation of various cellular processes, including inflammation, immune responses, and sensory perception. The ACKR2 receptor is a potential drug target due to its involvement in the development and progression of diseases. The inhibition of ACKR2 may be an effective way

Protein Name: Atypical Chemokine Receptor 2

Functions: Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Acts as a receptor for chemokines including CCL2, CCL3, CCL3L1, CCL4, CCL5, CCL7, CCL8, CCL11, CCL13, CCL17, CCL22, CCL23, CCL24, SCYA2/MCP-1, SCY3/MIP-1-alpha, SCYA5/RANTES and SCYA7/MCP-3. Upon active ligand stimulation, activates a beta-arrestin 1 (ARRB1)-dependent, G protein-independent signaling pathway that results in the phosphorylation of the actin-binding protein cofilin (CFL1) through a RAC1-PAK1-LIMK1 signaling pathway. Activation of this pathway results in up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. By scavenging chemokines in tissues, on the surfaces of lymphatic vessels, and in placenta, plays an essential role in the resolution (termination) of the inflammatory response and in the regulation of adaptive immune responses. Plays a major role in the immune silencing of macrophages during the resolution of inflammation. Acts as a regulator of inflammatory leukocyte interactions with lymphatic endothelial cells (LECs) and is required for immature/mature dendritic cells discrimination by LECs

The "ACKR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACKR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets